Regulatory note: Both BPC-157 and TB-500 are prohibited by WADA for athletic use and are not FDA-approved for human administration
Because retatrutide lowers blood glucose through multiple hormonal pathways, combining it with insulin or sulfonylureas (such as gliclazide or glibenclamide) may substantially increase the risk of hypoglycaemia
Table of contents What Is IM8
Polymorphisms in glutathione synthase, glutathione reductase, and glutathione S-transferase genes affect your baseline antioxidant capacity and detoxification efficiency
No safety studies exist for doses above 1,400 mg, which was only tested in Parkinsons disease research, not cosmetic applications
By the end, we hope to empower you with the knowledge needed to make informed decisions about your health